Jeffrey Nascimento, DO
Pulmonary Disease · Hartford, CTNPI 1235256934
Payments from drug & device makers
Across 886 payments — averaging $240.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$182K
- Boehringer Ingelheim$17K
- Axsome Therapeutics, Inc.$5K
- AstraZeneca$3K
- Harmony Biosciences LLC$888
- Jazz Pharmaceuticals Inc.$690
- plus $4K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 403 | $181,542 |
| Boehringer Ingelheim | 44 | $16,964 |
| Axsome Therapeutics, Inc. | 7 | $4,965 |
| AstraZeneca(2 entities) | 143 | $3,466 |
| Harmony Biosciences LLC | 34 | $888 |
| Jazz Pharmaceuticals Inc. | 32 | $690 |
| Mylan Specialty L.p. | 27 | $564 |
| Amgen | 14 | $412 |
| Regeneron Healthcare Solutions, Inc. | 19 | $410 |
| Electromed, Inc. | 30 | $313 |
| Verona Pharma, Inc. | 12 | $305 |
| Genentech USA, Inc. | 8 | $255 |
| Sunovion Pharmaceuticals Inc. | 22 | $244 |
| Avadel CNS Pharmaceuticals, LLC | 9 | $227 |
| Johnson & Johnson | 15 | $219 |
| Insmed, Inc. | 9 | $164 |
| Actelion Pharmaceuticals US, Inc. | 6 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $134 |
| E.r. Squibb & Sons, L.L.C. | 7 | $125 |
| Pfizer | 6 | $116 |
| Novartis | 4 | $86 |
| Merck | 4 | $80 |
| ZOLL Respicardia, Inc. | 2 | $66 |
| Circassia Inc. | 4 | $58 |
| Sanofi | 2 | $54 |
| Arbor Pharmaceuticals, Inc. | 2 | $43 |
| 3b Medical, Inc. | 2 | $37 |
| Grifols USA, LLC | 2 | $36 |
| Mallinckrodt Hospital Products Inc. | 2 | $34 |
| Viatris Specialty LLC | 1 | $34 |
| Philips North America LLC | 2 | $30 |
| AbbVie | 1 | $24 |
| Boston Scientific | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| Advanced Respiratory, Inc | 1 | $21 |
| Mallinckrodt Enterprises LLC | 1 | $16 |
| Eisai Inc. | 1 | $16 |
How this compares
$212,830 in reported general payments places this provider in the 90th percentile of 255 pulmonary disease providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Hartford
- Raj ParikhHartford$419K
- Patrick TroyHartford$385K
- Daniel GerardiHartford$156K
- James PopeHartford$125K
- John McArdleHartford$90K
- Anil MaggeHartford$74K
- Francoise RouxHartford$39K
- Eric ShoreHartford$35K
- John RussomannoHartford$18K
- Meredith HolubHartford$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.